相关实验视频

Updated: Jun 10, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

从包容的角度重新审视前列腺癌中的HER2:从生物标志物到Omics

Nicole Mavingire1, Janelle C Moore1, Jabril R Johnson2

  • 1Department of Surgery, Morehouse School of Medicine, Atlanta, GA 30310, USA.

Cancers
|October 16, 2024
PubMed
概括

人类表皮生长因子受体2 (HER2) 驱动前列腺癌的进展. 研究必须包括多样化的群体,特别是黑人男性,以了解HER2.

关键词:
黑人男人 黑人男人在ERBB2中,它是ERBB2.在HER2中,HER2是HER2.遗传祖先的遗传血统是什么俄米克斯 (omicsics) 是一个电子产品.前列腺癌是前列腺癌.

更多相关视频

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.8K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

618

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...